Cargando…
Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration
UDP-Glucose 6-dehydrogenase (UGDH) produces UDP-α-D-glucuronic acid, the precursors for glycosaminoglycans (GAGs) and proteoglycans (PGs) of the extracellular matrix. Elevated GAG formation has been implicated in a variety of human diseases, including glioblastoma (GBM). In our previous study, we fo...
Autores principales: | Oyinlade, Olutobi, Wei, Shuang, Lal, Bachchu, Laterra, John, Zhu, Heng, Goodwin, C. Rory, Wang, Shuyan, Ma, Ding, Wan, Jun, Xia, Shuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957772/ https://www.ncbi.nlm.nih.gov/pubmed/29479058 http://dx.doi.org/10.1038/s41388-018-0138-y |
Ejemplares similares
-
Targeting UDP-α-d-glucose 6-dehydrogenase alters the CNS tumor immune microenvironment and inhibits glioblastoma growth
por: Zhan, Daqian, et al.
Publicado: (2021) -
UDP-α-D-glucose 6-dehydrogenase: a promising target for glioblastoma
por: Goodwin, C. Rory, et al.
Publicado: (2019) -
Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells
por: Tung, Brian, et al.
Publicado: (2018) -
EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase
por: Wang, Shervin D., et al.
Publicado: (2012) -
UDP-glucose dehydrogenase (UGDH) in clinical oncology and cancer biology
por: Price, Meghan J., et al.
Publicado: (2023)